Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

52 Results

Guidelines and Advice

Contouring Nomenclature - Recommendation Report (Head and Neck Cancer)

Status: Current
ID: GL-C50-12

Feb 2014

Guidelines and Advice

Dose Objectives for Head and Neck IMRT Treatment Planning - Recommendation Report

Status: Current
ID: GL-C50-13

Feb 2014

Guidelines and Advice

Lung Cancer Imaging Guidelines: Integration with the Lung Cancer Diagnosis and Staging Clinical Pathway - Full Document

Status: Current
ID: GL-C50-11

Jan 2014

Guidelines and Advice

Ontario Oncology Information System Standards: Defining its Meaningful Use

Status: Current
ID: GL-C50-14

Mar 2014

Statistical Reports

Cancer Risk Factors in Ontario: Tobacco

Jan 2014

Statistical Reports

Cancer Risk Factors in Ontario: Alcohol

Apr 2014

Guidelines and Advice

Effectiveness of Screening With Annual Magnetic Resonance Imaging and Mammography: Results of the Initial Screen From the Ontario High Risk Breast Screening Program

Status: Current

Jun 2014

Guidelines and Advice

Integrating Care for Cancer Patients: An evidence-informed analysis

Jul 2014

Guidelines and Advice

Kadcyla® Trastuzumab Emtansine Safety Reminder

Status: Current
ID: GL-C50-15

Jun 2014

Guidelines and Advice

Acute Leukemia Provincial Plan

Status: Current
ID: GL-C50-34

Aug 2017

Guidelines and Advice

Hereditary Cancers Guideline: An Endorsement of the 2015 Standards and Guidelines for the Interpretation of Sequence Variants

Status: Current
ID: GL-END MOTAC 5

Aug 2017

Drug

triptorelin

Other Name(s): Trelstar® (Allergan Pharma)

Quick Link(s): Drug Monograph, Patient Info Sheet

Oct 2014

Pages